Tianjin Tianyao Pharmaceuticals Co., Ltd. Class ASSE: 600488

"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on Obtaining FDA DMF First Adequate Letter for Betamethasone Dipropionate API

· Issued by Tianjin Tianyao Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining FDA DMF First Adequate Letter for Betamethasone Dipropionate API

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment